Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Animal studies in diet-induced obese rats show tesofensine (2.0mg/kg) produces marked weight reduction accompanied by strong hypophagic responses
One should not use AOD-9604 if they: Are pregnant or breastfeeding Are a minor Have a current or recent history of cancer (particularly hormone-sensitive cancers) Have uncontrolled diabetes or significant insulin resistance Have active thyroid disease that is not well-managed Are taking medications that may interact with peptide therapy (discuss with your provider) Have a known hypersensitivity to peptide compounds Comprehensive labs including metabolic panel, fasting glucose, HbA1c, thyroid panel, lipid panel, and hormone levels should be run before starting any peptide therapy and monitored regularly throughout
(Study: Wadden et al., 2021) AOD 9604 Peptide AOD 9604 is a synthetic peptide designed to promote weight loss by mimicking the action of natural human growth hormone (hGH)
Its levels decline by 4060% with age, primarily due to increased CD38 activity and the heightened demand for PARP-1 for DNA repair
Blood pressure medications might require adjustment as weight loss progresses
